Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both β-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells
暂无分享,去创建一个
[1] S. Yuspa,et al. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis. , 1998, Journal of dermatological science.
[2] N. Colburn,et al. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. , 2005, Cancer research.
[3] Joshua G. Steffen,et al. AGL80 Is Required for Central Cell and Endosperm Development in Arabidopsis[W] , 2006, The Plant Cell Online.
[4] H. Allgayer,et al. Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors , 2007, Oncogene.
[5] M. Takeichi,et al. Cadherin cell adhesion receptors as a morphogenetic regulator. , 1991, Science.
[6] J. Winnie,et al. Transcriptional regulation of cell invasion: AP-1 regulation of a multigenic invasion programme. , 2000, European journal of cancer.
[7] K. Klempnauer,et al. Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun , 2004, Oncogene.
[8] H. Clevers,et al. Wnt signaling in the intestinal epithelium: from endoderm to cancer. , 2005, Genes & development.
[9] R. Kemler,et al. Classical cadherins. , 1992, Seminars in cell biology.
[10] N. Sonenberg,et al. The Transformation Suppressor Pdcd4 Is a Novel Eukaryotic Translation Initiation Factor 4A Binding Protein That Inhibits Translation , 2003, Molecular and Cellular Biology.
[11] Y. Narisawa,et al. Expression patterns of programmed cell death 4 protein in normal human skin and some representative skin lesions , 2007, Experimental dermatology.
[12] Iver Petersen,et al. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis , 2003, The Journal of pathology.
[13] H. Zhang,et al. Involvement of programmed cell death 4 in transforming growth factor-β1-induced apoptosis in human hepatocellular carcinoma , 2006, Oncogene.
[14] N. Colburn,et al. Expression of dominant negative Jun inhibits elevated AP-1 and NF-κB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes , 1998, Oncogene.
[15] W F Bodmer,et al. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[16] B. Ozanne,et al. AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44 , 1997, Molecular and cellular biology.
[17] Nahum Sonenberg,et al. A Novel Function of the MA-3 Domains in Transformation and Translation Suppressor Pdcd4 Is Essential for Its Binding to Eukaryotic Translation Initiation Factor 4A , 2004, Molecular and Cellular Biology.
[18] Wing H Wong,et al. Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary. , 2005, Cancer research.
[19] Hans Clevers,et al. Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.
[20] H. Allgayer,et al. Urokinase-Receptor (u-PAR)–An Essential Player in Multiple Games of Cancer: A Review on Its Role in Tumor Progression, Invasion, Metastasis, Proliferation/dormancy, Clinical Outcome and Minimal Residual Disease , 2006, Cell cycle.
[21] A. Kinsella,et al. Reduced E-cadherin expression correlates with increased invasiveness in colorectal carcinoma cell lines , 1994, Clinical & Experimental Metastasis.
[22] B. Ozanne,et al. Fos-transformation activates genes associated with invasion. , 1994, Oncogene.
[23] N. Colburn,et al. Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. , 2004, Molecular cancer therapeutics.
[24] R. Roeder,et al. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.
[25] Gerhard Christofori,et al. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer , 2004, Nature Reviews Cancer.
[26] Xi He,et al. Adenomatous Polyposis Coli (APC) Differentially Regulates β-Catenin Phosphorylation and Ubiquitination in Colon Cancer Cells* , 2006, Journal of Biological Chemistry.
[27] Chunhong Ma,et al. Frequent loss of PDCD4 expression in human glioma: possible role in the tumorigenesis of glioma. , 2007, Oncology reports.
[28] M. Mareel,et al. Immunohistochemical analysis of E-cadherin expression in human colorectal tumours. , 1993, Pathology, research and practice.
[29] Jennifer L. Knies,et al. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation , 2003, Oncogene.
[30] Kyuyoung Song,et al. Differential expression in normal-adenoma-carcinoma sequence suggests complex molecular carcinogenesis in colon. , 2006, Oncology reports.
[31] N. Colburn,et al. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-κB or ODC transactivation , 2001, Oncogene.
[32] F. Portillo,et al. Transcriptional regulation of cadherins during development and carcinogenesis. , 2004, The International journal of developmental biology.
[33] N. Colburn,et al. Tumorigenesis Suppressor Pdcd4 Down-Regulates Mitogen-Activated Protein Kinase Kinase Kinase Kinase 1 Expression To Suppress Colon Carcinoma Cell Invasion , 2006, Molecular and Cellular Biology.